Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$846M |
| 2 |
JD.com
JD
|
+$782M |
| 3 |
Dollar General
DG
|
+$647M |
| 4 |
Monster Beverage
MNST
|
+$324M |
| 5 |
NXP Semiconductors
NXPI
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$668M |
| 2 |
Mondelez International
MDLZ
|
+$528M |
| 3 |
Alibaba
BABA
|
+$457M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$409M |
| 5 |
CELG
Celgene Corp
CELG
|
+$403M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.97% |
| 2 | Consumer Discretionary | 16.01% |
| 3 | Technology | 12.95% |
| 4 | Communication Services | 12.43% |
| 5 | Financials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESL
701
DELISTED
Esterline Technologies
ESL
| $588K | ﹤0.01% |
6,164
-290
| -4% | -$31K |
|
702
Cummins
CMI
$83.6B
| $565K | ﹤0.01% |
4,310
-22,118
| -84% | -$3.04M |
|
|
IMPV
703
DELISTED
Imperva, Inc.
IMPV
| $510K | ﹤0.01% |
7,526
-9,502
| -56% | -$524K |
|
704
Xylem
XYL
$28.5B
| $487K | ﹤0.01% |
+13,148
| New | +$478K |
|
|
PRXL
705
DELISTED
Parexel International Corp
PRXL
| $484K | ﹤0.01% |
7,531
-359
| -5% | -$24.2K |
|
706
Terex
TEX
$7.37B
| $476K | ﹤0.01% |
20,485
-1,496,876
| -99% | -$39.5M |
|
707
AGCO
AGCO
$8.41B
| $458K | ﹤0.01% |
+8,070
| New | +$410K |
|
708
NETGEAR
NTGR
$612M
| $451K | ﹤0.01% |
15,007
-14,069
| -48% | -$441K |
|
709
InspireMD
NSPR
$31.4M
| – | – |
0
| – | – |
|
710
Skyworks Solutions
SWKS
$9.2B
| $438K | ﹤0.01% |
4,205
-101
| -2% | -$10.2K |
|
|
INFA
711
DELISTED
INFORMATICA CORP
INFA
| $437K | ﹤0.01% |
+9,014
| New | +$434K |
|
|
SGNT
712
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $431K | ﹤0.01% |
17,726
+3,842
| +28% | +$92K |
|
713
ON Semiconductor
ON
$30.7B
| $414K | ﹤0.01% |
35,401
+2,372
| +7% | +$29.1K |
|
|
NUVA
714
DELISTED
NuVasive, Inc.
NUVA
| $409K | ﹤0.01% |
+8,631
| New | +$404K |
|
715
Evercore
EVR
$11.8B
| $400K | ﹤0.01% |
7,416
-8,295
| -53% | -$423K |
|
716
City Holding Co
CHCO
$2.05B
| $392K | ﹤0.01% |
+7,957
| New | +$374K |
|
|
NVTA
717
DELISTED
Invitae Corporation
NVTA
| $391K | ﹤0.01% |
26,261
+79
| +0.3% | +$1.12K |
|
|
FNSR
718
DELISTED
Finisar Corp
FNSR
| $369K | ﹤0.01% |
20,637
-3,499
| -14% | -$74.3K |
|
719
Raymond James Financial
RJF
$33.5B
| $368K | ﹤0.01% |
+9,264
| New | +$360K |
|
720
Comscore
SCOR
$113M
| $362K | ﹤0.01% |
+340
| New | +$367K |
|
|
WFM
721
DELISTED
Whole Foods Market Inc
WFM
| $355K | ﹤0.01% |
8,999
-1,049,876
| -99% | -$47M |
|
722
Trip.com Group
TCOM
$29B
| $344K | ﹤0.01% |
9,474
+830
| +10% | +$29K |
|
723
Community Health Systems
CYH
$382M
| $330K | ﹤0.01% |
+6,339
| New | +$284K |
|
|
OCR
724
DELISTED
OMNICARE INC
OCR
| $288K | ﹤0.01% |
+3,060
| New | +$273K |
|
|
CBPO
725
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $276K | ﹤0.01% |
+2,397
| New | +$252K |
|
Similar funds
Jennison Associates's Q2 2015 Portfolio in Review
As of Q2 2015, Jennison Associates held 801 positions worth $109B, down 0.05% from $109B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Jennison Associates's Q2 2015 filing shows 92 new, 315 increased, 305 reduced and 72 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 1,732,726 shares worth $884M. The largest sale was Union Pacific, an estimated $668M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jennison Associates's largest Q2 2015 buy was Regeneron Pharmaceuticals: 1,732,726 shares worth $884M.
- Jennison Associates added most to JD.com in Q2 2015, an estimated $782M increase.
- Jennison Associates's biggest Q2 2015 reduction was Union Pacific, cutting an estimated $668M.
- Jennison Associates fully exited Perrigo in Q2 2015, selling an estimated $204M.
- Jennison Associates's ten largest holdings make up 21% of its $109B portfolio in Q2 2015.
- Jennison Associates opened 92 new positions and closed 72 in Q2 2015.
- Jennison Associates's portfolio value fell 0.05% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q2 2015, filed 3 Aug 2015.